Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016:2016:2129838.
doi: 10.1155/2016/2129838. Epub 2016 Sep 6.

Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial

James F Graumlich  1 , Huaping Wang  2 , Anna Madison  3 , Michael S Wolf  4 , Darren Kaiser  5 , Kumud Dahal  6 , Daniel G Morrow  7
Affiliations
Randomized Controlled Trial

Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial

James F Graumlich et al. J Diabetes Res. 2016.

Abstract

Among patients with various levels of health literacy, the effects of collaborative, patient-provider, medication-planning tools on outcomes relevant to self-management are uncertain. Objective. Among adult patients with type II diabetes mellitus, we tested the effectiveness of a medication-planning tool (Medtable™) implemented via an electronic medical record to improve patients' medication knowledge, adherence, and glycemic control compared to usual care. Design. A multicenter, randomized controlled trial in outpatient primary care clinics. 674 patients received either the Medtable tool or usual care and were followed up for up to 12 months. Results. Patients who received Medtable had greater knowledge about indications for medications in their regimens and were more satisfied with the information about their medications. Patients' knowledge of drug indication improved with Medtable regardless of their literacy status. However, Medtable did not improve patients' demonstrated medication use, regimen adherence, or glycemic control (HbA1c). Conclusion. The Medtable tool supported provider/patient collaboration related to medication use, as reflected in patient satisfaction with communication, but had limited impact on patient medication knowledge, adherence, and HbA1c outcomes. This trial is registered with ClinicalTrials.gov NCT01296633.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Example of Medtable. The patient and provider collaborate to choose times for each medication in the regimen. Modified and reprinted from [27] with permission from Elsevier.
Figure 2
Figure 2
Trial flow diagram.
Figure 3
Figure 3
Medication adherence and glycosylated hemoglobin (HbA1c) before and after intervention: Medtable versus usual care.
See this image and copyright information in PMC

References

    1. American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32(supplement 1):S13–S61. doi: 10.2337/dc09-s013. - DOI - PMC - PubMed
    1. Aspden P., Wolcott J., Bootman J. L., Croenwett L. R. Preventing Medication Errors. Washington, DC, USA: The National Academies Press; 2007.
    1. Osterberg L., Blaschke T. Adherence to medication. The New England Journal of Medicine. 2005;353(5):487–497. doi: 10.1056/nejmra050100. - DOI - PubMed
    1. Paasche-Orlow M. K., Schillinger D., Greene S. M., Wagner E. H. How health care systems can begin to address the challenge of limited literacy. Journal of General Internal Medicine. 2006;21(8):884–887. doi: 10.1111/j.1525-1497.2006.00544.x. - DOI - PMC - PubMed
    1. Wolf M. S., Curtis L. M., Waite K., et al. Helping patients simplify and safely use complex prescription regimens. Archives of Internal Medicine. 2011;171(4):300–305. doi: 10.1001/archinternmed.2011.39. - DOI - PMC - PubMed

Publication types

Associated data